Lung (includes NSCLC, SCLC, Mesothelioma)
Featured Articles
(Morningstar) June 22, 2017 - The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific for the first next-generation sequencing (NGS)-based test that simultaneously screens tumor samples for biomarkers associated with three FDA-approved therapies for non-small cell lung cancer (NSCLC).
Read Article
(ASCO in Action) June 22, 2017 - On June 22, 2017, the U.S. Food and Drug Administration granted regular approvals to dabrafenib and trametinib (TAFINLAR® and MEKINIST®, Novartis Pharmaceuticals Inc.) administered in combination for patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation as detected by an...
Read Article
Latest Articles
June 23, 2017
June 23, 2017
June 22, 2017
June 22, 2017
June 19, 2017
June 19, 2017
June 19, 2017
June 16, 2017
View More
News Commentary
Editor Image
06 Mar, 2017 | by H. Jack West, MD
I'm dubious about a 62% specificity. The test doesn't conclusively rule out...
View Comment
Editor Image
24 Mar, 2017 | by H. Jack West, MD
It's striking that we've needed yet another revision of the NCCN guidelines in...
View Comment
View More
OBR Green
There are no Lung (includes NSCLC, SCLC, Mesothelioma) OBR Green articles.
OBR Blog
There are no Lung (includes NSCLC, SCLC, Mesothelioma) blog entries.